Source:http://linkedlifedata.com/resource/pubmed/id/12858019
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-7-14
|
pubmed:abstractText |
Transforming growth factor-beta1 (TGF-beta1) can act as both a tumor suppressor and a stimulator of tumor progression. We have examined the relationship between polymorphisms of the TGF-beta1 gene and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection. A total of 1,237 Korean subjects were prospectively enrolled; 1,046 patients with chronic HBV infection and 191 healthy controls with no evidence of recent or remote HBV infection. The patients were divided into two groups: those without (n = 809) and those with HCC (n = 237). Single nucleotide polymorphisms (SNPs) of TGF-beta1 were searched for and genotyped using the single base extension method. In Korean subjects, only two SNPs were found among the seven known polymorphisms of TGF-beta1, at position -509 and in codon 10. The risk of HCC was significantly lower in patients with the T/T or C/T genotypes than in those with the C/C genotypes at position -509 (P < 0.02), and also lower among those with the Pro/Pro or Leu/Pro genotypes than in those with the Leu/Leu genotypes in codon 10 (P < 0.007). Haplotype analysis revealed that the possession of [-509C > T; L10P] conferred a decreased likelihood of HCC (OR = 0.74; 95% CI, 0.59-0.93; P = 0.008). In conclusion, the presence of the TGF-beta1 -509C > T promoter or of the L10P polymorphism, and the combination of both [-509C > T; L10P] as a haplotype were strongly associated with a reduced risk of HCC in patients with chronic HBV infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1226-3613
|
pubmed:author |
pubmed-author:ImJong PilJP,
pubmed-author:JeongJi BongJB,
pubmed-author:JungJi HyunJH,
pubmed-author:KimChung YongCY,
pubmed-author:KimHyun-DaeHD,
pubmed-author:KimJun YeonJY,
pubmed-author:KimLyoung HyoLH,
pubmed-author:KimMyung SooMS,
pubmed-author:KimYoon JunYJ,
pubmed-author:LeeHyo-SukHS,
pubmed-author:MinByung-HoonBH,
pubmed-author:ParkByung LaeBL,
pubmed-author:ShinHyoung DooHD,
pubmed-author:YoonJung-HwanJH
|
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
196-202
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12858019-Adult,
pubmed-meshheading:12858019-Aged,
pubmed-meshheading:12858019-Carcinoma, Hepatocellular,
pubmed-meshheading:12858019-Female,
pubmed-meshheading:12858019-Genetic Variation,
pubmed-meshheading:12858019-Hepatitis B,
pubmed-meshheading:12858019-Humans,
pubmed-meshheading:12858019-Liver Neoplasms,
pubmed-meshheading:12858019-Male,
pubmed-meshheading:12858019-Middle Aged,
pubmed-meshheading:12858019-Polymorphism, Single Nucleotide,
pubmed-meshheading:12858019-Risk Factors,
pubmed-meshheading:12858019-Transforming Growth Factor beta,
pubmed-meshheading:12858019-Transforming Growth Factor beta1
|
pubmed:year |
2003
|
pubmed:articleTitle |
Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
|
pubmed:affiliation |
Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|